Since HIV is not associated with notable elevation of CSF p-tau or depression in Aβ42 that characterize Alzheimer's disease, these biomarkers can be used to identify the latter in HIV patients suffering deteriorating cognition and help to monitor any increase in Alzheimer's disease prevalence in treated HIV infection. The gene discussed is MAPT; the disease is Alzheimer disease.